Visible‐Light‐Controlled Lysine‐Selective Crosslinking Decodes Protein Complexes and Dynamic Interactomes in Live Cells

Y Yali Xu (State Key Laboratory of Drug Research) H Hao Hu Y Yu Ran W Wensi Zhao (Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People’s Hospital, and Cancer Center, School of Medicine) A An‐Di Guo (State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China) H Hui‐Jun Nie (State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China) L Linhui Zhai (Translational Research Institute of Brain and Brain‐Like Intelligence School of Medicine Shanghai Fourth People's Hospital Tongji University Shanghai China) G Guang‐Liang Yin (State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China) J Jintao Cheng (Life Sciences Institute Zhejiang University Hangzhou 310058 China) S Shengna Tao (State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China) B Bing Yang M Minjia Tan (State Key Laboratory of Drug Research) X Xiao‐Hua Chen (State Key Laboratory of Drug Research Chinese Academy of Sciences Shanghai Institute of Materia Medica Shanghai P. R. China)

Abstract

Abstract Crosslinking strategies have emerged as an attractive technology for deciphering protein complexes and protein–protein interactions (PPIs). However, commonly used crosslinking strategies present significant challenges for the precise analysis of protein complexes and dynamic PPIs in native biological environments. Here, we report the development of the first visible‐light‐inducible lysine‐specific homobifunctional photo‐crosslinkers and introduce V isible‐light‐controlled L ysine‐selective crosslinking (VL‐XL) strategy for in‐depth analysis of protein complexes and profiling dynamic interactomes in live cells. By synergistically integrating the advantages of temporal control, high biocompatibility, and lysine selectivity, the VL‐XL strategy not only provides an effective solution for protein complexes studies—achieving residue‐specific crosslinked peptides, delivering high‐confidence data and streamlined mass spectrometry (MS) data analysis—but also reveals dynamic interactomes in various scenarios. The VL‐XL strategy successfully profiles the time‐resolved, epidermal growth factor (EGF)‐stimulated epidermal growth factor receptor (EGFR) interactome, providing valuable insights into regulatory mechanisms of EGFR signaling. More importantly, the VL‐XL strategy effectively unveils molecular glue degrader‐induced E3 ligase interactome, leading to discovery of neo‐substrates such as Sestrin‐2 (SESN2) and opening an innovative avenue for identifying novel targets for degradation. Overall, the VL‐XL strategy provides a robust chemical tool, inspiring innovative solutions to address unresolved questions in multiple fields.

Article Details

Volume / Issue Vol. 64, Issue 32
Published August 04, 2025
ISSN 1433-7851
Publisher Wiley

Journal Info

Angewandte Chemie International Edition

Wiley

ISSN: 1433-7851 Physical Sciences

Authors (13)

Y

Yali Xu

State Key Laboratory of Drug Research

H

Hao Hu

Y

Yu Ran

W

Wensi Zhao

Translational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People’s Hospital, and Cancer Center, School of Medicine

A

An‐Di Guo

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China

H

Hui‐Jun Nie

State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China

L

Linhui Zhai

Translational Research Institute of Brain and Brain‐Like Intelligence School of Medicine Shanghai Fourth People's Hospital Tongji University Shanghai China

G

Guang‐Liang Yin

State Key Laboratory of Drug Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China

J

Jintao Cheng

Life Sciences Institute Zhejiang University Hangzhou 310058 China

S

Shengna Tao

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai 201203 China

B

Bing Yang

M

Minjia Tan

State Key Laboratory of Drug Research

X

Xiao‐Hua Chen

State Key Laboratory of Drug Research Chinese Academy of Sciences Shanghai Institute of Materia Medica Shanghai P. R. China